LysoPE(20:4)
|
Basic information |
| Metabolite name | LysoPE(20:4) |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | LysoPE(20:4) |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | LysoPE(20:4) |
| N/A |
|
N/A |
|
N/A |
| Synonyms | LysoPE(20:4) |
| No. of studies | 5 |
|
Relationship between LysoPE(20:4) and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Up |
| Study M123 | Type3 | rTMS group vs. control group | Striatum | Wistar rat | Up |
| Study M125 | Type1 | depressed group vs. control group | Plasma | Human | Up |
| Study M512 | Type1 | CUMS group vs. control group | Urine | Goto-Kakizaki rat | Down |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Medial prefrontal cortex | C57BL/6 J mouse | Up |